<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 10 Aug 2026 09:10:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>AI Found an Influenza Target That Survives Viral Mutation</title>
   <link>http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;AUSTIN, Texas, Aug.  10, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Equity Insider&lt;/a&gt; &lt;strong&gt;News Commentary&lt;/strong&gt; - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;MindWalk Holdings Corp.&lt;/a&gt; (Nasdaq: HYFT) has built its entire technology stack around that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html</guid>
   <pubDate>Mon, 10 Aug 2026 09:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SDGR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TEM</category>
   	  </item>
  <item>
   <title>AI Found an Influenza Target That Survives Viral Mutation</title>
   <link>http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;AUSTIN, Texas, Aug.  10, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Equity Insider&lt;/a&gt; &lt;strong&gt;News Commentary&lt;/strong&gt; - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;MindWalk Holdings Corp.&lt;/a&gt; (Nasdaq: HYFT) has built its entire technology stack around that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html</guid>
   <pubDate>Mon, 10 Aug 2026 09:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SDGR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TEM</category>
   	  </item>
  <item>
   <title>AI Found an Influenza Target That Survives Viral Mutation</title>
   <link>http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;AUSTIN, Texas, Aug.  10, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Equity Insider&lt;/a&gt; &lt;strong&gt;News Commentary&lt;/strong&gt; - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;MindWalk Holdings Corp.&lt;/a&gt; (Nasdaq: HYFT) has built its entire technology stack around that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html</guid>
   <pubDate>Mon, 10 Aug 2026 09:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SDGR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TEM</category>
   	  </item>
  <item>
   <title>AI Found an Influenza Target That Survives Viral Mutation</title>
   <link>http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;AUSTIN, Texas, Aug.  10, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Equity Insider&lt;/a&gt; &lt;strong&gt;News Commentary&lt;/strong&gt; - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;MindWalk Holdings Corp.&lt;/a&gt; (Nasdaq: HYFT) has built its entire technology stack around that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html</guid>
   <pubDate>Mon, 10 Aug 2026 09:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SDGR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TEM</category>
   	  </item>
  <item>
   <title>AI Found an Influenza Target That Survives Viral Mutation</title>
   <link>http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;AUSTIN, Texas, Aug.  10, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Equity Insider&lt;/a&gt; &lt;strong&gt;News Commentary&lt;/strong&gt; - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;MindWalk Holdings Corp.&lt;/a&gt; (Nasdaq: HYFT) has built its entire technology stack around that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html</guid>
   <pubDate>Mon, 10 Aug 2026 09:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SDGR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TEM</category>
   	  </item>
  <item>
   <title>AI Found an Influenza Target That Survives Viral Mutation</title>
   <link>http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;AUSTIN, Texas, Aug.  10, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Equity Insider&lt;/a&gt; &lt;strong&gt;News Commentary&lt;/strong&gt; - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;MindWalk Holdings Corp.&lt;/a&gt; (Nasdaq: HYFT) has built its entire technology stack around that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html</guid>
   <pubDate>Mon, 10 Aug 2026 09:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SDGR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TEM</category>
   	  </item>
  <item>
   <title>AI Found an Influenza Target That Survives Viral Mutation</title>
   <link>http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;AUSTIN, Texas, Aug.  10, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Equity Insider&lt;/a&gt; &lt;strong&gt;News Commentary&lt;/strong&gt; - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;MindWalk Holdings Corp.&lt;/a&gt; (Nasdaq: HYFT) has built its entire technology stack around that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html</guid>
   <pubDate>Mon, 10 Aug 2026 09:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SDGR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TEM</category>
   	  </item>
  <item>
   <title>AI Found an Influenza Target That Survives Viral Mutation</title>
   <link>http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;AUSTIN, Texas, Aug.  10, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Equity Insider&lt;/a&gt; &lt;strong&gt;News Commentary&lt;/strong&gt; - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;MindWalk Holdings Corp.&lt;/a&gt; (Nasdaq: HYFT) has built its entire technology stack around that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html</guid>
   <pubDate>Mon, 10 Aug 2026 09:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SDGR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TEM</category>
   	  </item>
  <item>
   <title>AI Found an Influenza Target That Survives Viral Mutation</title>
   <link>http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;AUSTIN, Texas, Aug.  10, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Equity Insider&lt;/a&gt; &lt;strong&gt;News Commentary&lt;/strong&gt; - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;MindWalk Holdings Corp.&lt;/a&gt; (Nasdaq: HYFT) has built its entire technology stack around that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html</guid>
   <pubDate>Mon, 10 Aug 2026 09:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SDGR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TEM</category>
   	  </item>
  <item>
   <title>AI Found an Influenza Target That Survives Viral Mutation</title>
   <link>http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;AUSTIN, Texas, Aug.  10, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Equity Insider&lt;/a&gt; &lt;strong&gt;News Commentary&lt;/strong&gt; - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;MindWalk Holdings Corp.&lt;/a&gt; (Nasdaq: HYFT) has built its entire technology stack around that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html</guid>
   <pubDate>Mon, 10 Aug 2026 09:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SDGR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TEM</category>
   	  </item>
  <item>
   <title>AI Found an Influenza Target That Survives Viral Mutation</title>
   <link>http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;AUSTIN, Texas, Aug.  10, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Equity Insider&lt;/a&gt; &lt;strong&gt;News Commentary&lt;/strong&gt; - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;MindWalk Holdings Corp.&lt;/a&gt; (Nasdaq: HYFT) has built its entire technology stack around that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html</guid>
   <pubDate>Mon, 10 Aug 2026 09:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SDGR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TEM</category>
   	  </item>
  <item>
   <title>AI Found an Influenza Target That Survives Viral Mutation</title>
   <link>http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;AUSTIN, Texas, Aug.  10, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Equity Insider&lt;/a&gt; &lt;strong&gt;News Commentary&lt;/strong&gt; - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;MindWalk Holdings Corp.&lt;/a&gt; (Nasdaq: HYFT) has built its entire technology stack around that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html</guid>
   <pubDate>Mon, 10 Aug 2026 09:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SDGR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TEM</category>
   	  </item>
  <item>
   <title>Form  EFFECT     MindWalk Holdings Corp.              </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++MindWalk+Holdings+Corp.++++++++++++++/26846136.html</link>
   <description>si-local-file:///var/storage/secattach/20260731/26846136.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++MindWalk+Holdings+Corp.++++++++++++++/26846136.html</guid>
   <pubDate>Fri, 31 Jul 2026 06:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02598349</category>
   	  </item>
  <item>
   <title>Form  EFFECT     MindWalk Holdings Corp.              </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++MindWalk+Holdings+Corp.++++++++++++++/26846136.html</link>
   <description>si-local-file:///var/storage/secattach/20260731/26846136.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++MindWalk+Holdings+Corp.++++++++++++++/26846136.html</guid>
   <pubDate>Fri, 31 Jul 2026 06:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02598349</category>
   	  </item>
  <item>
   <title>MindWalk (HYFT) files $200M mixed shelf</title>
   <link>http://www.streetinsider.com/Earnings/MindWalk+%28HYFT%29+files+%24200M+mixed+shelf/26821749.html</link>
   <description>&lt;p&gt;MindWalk (NASDAQ: HYFT) on Tuesday filed $200,000,000 mixed shelf of:&lt;/p&gt;&lt;p&gt;Common Shares&lt;/p&gt;&lt;p&gt;Preferred Shares&lt;/p&gt;&lt;p&gt;Debt Securities&lt;/p&gt;&lt;p&gt;Warrants&lt;/p&gt;&lt;p&gt;Units&lt;/p&gt;&lt;p&gt;Subscription Receipts&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Earnings/MindWalk+%28HYFT%29+files+%24200M+mixed+shelf/26821749.html</guid>
   <pubDate>Tue, 28 Jul 2026 06:08:21 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	  </item>
  <item>
   <title>MindWalk (HYFT) files $200M mixed shelf</title>
   <link>http://www.streetinsider.com/Corporate+News/MindWalk+%28HYFT%29+files+%24200M+mixed+shelf/26821749.html</link>
   <description>&lt;p&gt;MindWalk (NASDAQ: HYFT) on Tuesday filed $200,000,000 mixed shelf of:&lt;/p&gt;&lt;p&gt;Common Shares&lt;/p&gt;&lt;p&gt;Preferred Shares&lt;/p&gt;&lt;p&gt;Debt Securities&lt;/p&gt;&lt;p&gt;Warrants&lt;/p&gt;&lt;p&gt;Units&lt;/p&gt;&lt;p&gt;Subscription Receipts&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/MindWalk+%28HYFT%29+files+%24200M+mixed+shelf/26821749.html</guid>
   <pubDate>Tue, 28 Jul 2026 06:08:21 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	  </item>
  <item>
   <title>Form  F-3/A      MindWalk Holdings Corp.              </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++F-3A++++++MindWalk+Holdings+Corp.++++++++++++++/26821406.html</link>
   <description>si-local-file:///var/storage/secattach/20260728/26821406.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++F-3A++++++MindWalk+Holdings+Corp.++++++++++++++/26821406.html</guid>
   <pubDate>Tue, 28 Jul 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02598349</category>
   	  </item>
  <item>
   <title>Form  F-3/A      MindWalk Holdings Corp.              </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++F-3A++++++MindWalk+Holdings+Corp.++++++++++++++/26821406.html</link>
   <description>si-local-file:///var/storage/secattach/20260728/26821406.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++F-3A++++++MindWalk+Holdings+Corp.++++++++++++++/26821406.html</guid>
   <pubDate>Tue, 28 Jul 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02598349</category>
   	  </item>
  <item>
   <title>Form  6-K        MindWalk Holdings Corp.   For: Jul 23</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++MindWalk+Holdings+Corp.+++For%3A+Jul+23/26808045.html</link>
   <description>si-local-file:///var/storage/secattach/20260723/26808045.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++MindWalk+Holdings+Corp.+++For%3A+Jul+23/26808045.html</guid>
   <pubDate>Thu, 23 Jul 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02598349</category>
   	  </item>
  <item>
   <title>Form  6-K        MindWalk Holdings Corp.   For: Jul 23</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++MindWalk+Holdings+Corp.+++For%3A+Jul+23/26808045.html</link>
   <description>si-local-file:///var/storage/secattach/20260723/26808045.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++MindWalk+Holdings+Corp.+++For%3A+Jul+23/26808045.html</guid>
   <pubDate>Thu, 23 Jul 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02598349</category>
   	  </item>
  <item>
   <title>MindWalk demos ReefIQ drug discovery tool at AMD AI event</title>
   <link>http://www.streetinsider.com/Corporate+News/MindWalk+demos+ReefIQ+drug+discovery+tool+at+AMD+AI+event/26807888.html</link>
   <description>&lt;p&gt;MindWalk Holdings Corp. (NASDAQ: HYFT) gave the first public demonstration of its ReefIQ biological context layer for AI drug discovery at AMD's Advancing AI 2026 conference in San Francisco, according to a press release from the company.&lt;/p&gt;&lt;p&gt;ReefIQ, which MindWalk introduced in June 2026, sits between client discovery data and AI reasoning workflows. The demonstration showed how the product connects fragmented drug-discovery data into queryable biological context, running on AMD Instinct compute hardware. MindWalk appeared in one of four custom demo segments in the AMD Instinct Demo Showcase, along with a video interview distributed through AMD's channels.&lt;/p&gt;&lt;p&gt;MindWalk describes ReefIQ as a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/MindWalk+demos+ReefIQ+drug+discovery+tool+at+AMD+AI+event/26807888.html</guid>
   <pubDate>Thu, 23 Jul 2026 16:02:31 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	  </item>
  <item>
   <title>MindWalk Showcases ReefIQ™ for AI Drug Discovery at AMD Advancing AI</title>
   <link>http://www.streetinsider.com/Press+Releases/MindWalk+Showcases+ReefIQ%E2%84%A2+for+AI+Drug+Discovery+at+AMD+Advancing+AI/26807881.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;At Advancing AI 2026, MindWalk unveils the first public demonstration of ReefIQ, its biological context layer for AI drug discovery, running on AMD Instinct™.&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    AUSTIN, Texas--(BUSINESS WIRE)--
MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today unveiled the first public demonstration of ReefIQ™, its biological context layer for AI drug discovery, running on AMD Instinct™ at AMD’s Advancing AI 2026 in San Francisco. MindWalk is featured in the AMD Instinct™ Demo Showcase, appearing in one of four custom demo vignettes, with an accompanying video interview distributed through AMD’s channels.

&lt;/p&gt;&lt;p id=&quot;news-body-cta&quot;&gt;This press release features multimedia. View the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MindWalk+Showcases+ReefIQ%E2%84%A2+for+AI+Drug+Discovery+at+AMD+Advancing+AI/26807881.html</guid>
   <pubDate>Thu, 23 Jul 2026 16:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02598349</category>
   	  </item>
  <item>
   <title>MindWalk Showcases ReefIQ™ for AI Drug Discovery at AMD Advancing AI</title>
   <link>http://www.streetinsider.com/Press+Releases/MindWalk+Showcases+ReefIQ%E2%84%A2+for+AI+Drug+Discovery+at+AMD+Advancing+AI/26807881.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;At Advancing AI 2026, MindWalk unveils the first public demonstration of ReefIQ, its biological context layer for AI drug discovery, running on AMD Instinct™.&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    AUSTIN, Texas--(BUSINESS WIRE)--
MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today unveiled the first public demonstration of ReefIQ™, its biological context layer for AI drug discovery, running on AMD Instinct™ at AMD’s Advancing AI 2026 in San Francisco. MindWalk is featured in the AMD Instinct™ Demo Showcase, appearing in one of four custom demo vignettes, with an accompanying video interview distributed through AMD’s channels.

&lt;/p&gt;&lt;p id=&quot;news-body-cta&quot;&gt;This press release features multimedia. View the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MindWalk+Showcases+ReefIQ%E2%84%A2+for+AI+Drug+Discovery+at+AMD+Advancing+AI/26807881.html</guid>
   <pubDate>Thu, 23 Jul 2026 16:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02598349</category>
   	  </item>
  <item>
   <title>MindWalk Showcases ReefIQ™ for AI Drug Discovery at AMD Advancing AI</title>
   <link>http://www.streetinsider.com/Business+Wire/MindWalk+Showcases+ReefIQ%E2%84%A2+for+AI+Drug+Discovery+at+AMD+Advancing+AI/26807881.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;At Advancing AI 2026, MindWalk unveils the first public demonstration of ReefIQ, its biological context layer for AI drug discovery, running on AMD Instinct™.&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    AUSTIN, Texas--(BUSINESS WIRE)--
MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today unveiled the first public demonstration of ReefIQ™, its biological context layer for AI drug discovery, running on AMD Instinct™ at AMD’s Advancing AI 2026 in San Francisco. MindWalk is featured in the AMD Instinct™ Demo Showcase, appearing in one of four custom demo vignettes, with an accompanying video interview distributed through AMD’s channels.

&lt;/p&gt;&lt;p id=&quot;news-body-cta&quot;&gt;This press release features multimedia. View the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/MindWalk+Showcases+ReefIQ%E2%84%A2+for+AI+Drug+Discovery+at+AMD+Advancing+AI/26807881.html</guid>
   <pubDate>Thu, 23 Jul 2026 16:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02598349</category>
   	  </item>
  <item>
   <title>MindWalk Showcases ReefIQ™ for AI Drug Discovery at AMD Advancing AI</title>
   <link>http://www.streetinsider.com/Business+Wire/MindWalk+Showcases+ReefIQ%E2%84%A2+for+AI+Drug+Discovery+at+AMD+Advancing+AI/26807881.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;At Advancing AI 2026, MindWalk unveils the first public demonstration of ReefIQ, its biological context layer for AI drug discovery, running on AMD Instinct™.&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    AUSTIN, Texas--(BUSINESS WIRE)--
MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today unveiled the first public demonstration of ReefIQ™, its biological context layer for AI drug discovery, running on AMD Instinct™ at AMD’s Advancing AI 2026 in San Francisco. MindWalk is featured in the AMD Instinct™ Demo Showcase, appearing in one of four custom demo vignettes, with an accompanying video interview distributed through AMD’s channels.

&lt;/p&gt;&lt;p id=&quot;news-body-cta&quot;&gt;This press release features multimedia. View the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/MindWalk+Showcases+ReefIQ%E2%84%A2+for+AI+Drug+Discovery+at+AMD+Advancing+AI/26807881.html</guid>
   <pubDate>Thu, 23 Jul 2026 16:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02598349</category>
   	  </item>
 </channel>
</rss>
